本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

5.53
+0.19003.56%
盘后:5.530.00000.00%16:10 EDT
成交量:5.73万
成交额:31.26万
市值:3,453.26万
市盈率:-0.76
高:5.64
开:5.50
低:5.30
收:5.34
52周最高:13.69
52周最低:3.98
股本:624.46万
流通股本:368.17万
量比:2.25
换手率:1.56%
股息:- -
股息率:- -
每股收益(TTM):-7.3016
每股收益(LYR):-2.4500
净资产收益率:-113.59%
总资产收益率:-49.12%
市净率:1.08
市盈率(LYR):-2.26

数据加载中...

2025/06/26

重要事件披露

Form 8-K - Current report
2025/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/04/02

SEC问询函

Form CORRESP - Correspondence
2025/03/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/10

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/02/12

重要事件披露

Form 8-K - Current report
2025/02/03

重要事件披露

Form 8-K - Current report
2024/11/15

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/09/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors